We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.66 | -0.75% | 86.79 | 86.13 | 87.30 | 87.28 | 86.14 | 87.09 | 1,201,342 | 16:40:00 |
From Apr 2019 to Apr 2024
Sanofi denied that its vaccine, the world's first against dengue, had caused any deaths. "There is currently no evidence directly linking the Dengvaxia vaccine to any of the 14 deaths," a spokesman responded in an email. "In Dengvaxia clinical trials conducted over more than a decade and the over one million doses of the vaccine administered, no deaths related to the vaccine have been reported to us."
"Initial Philippines Probe Finds 'Causal Association' Between Deaths, Sanofi Dengue Vaccine," published at 8:54 a.m. ET on Feb. 2, didn't include a more detailed company response.
(END) Dow Jones Newswires
February 15, 2018 11:45 ET (16:45 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
